VERU INC (Germany) Today
| FMW Stock | EUR 0.68 0.01 1.45% |
Performance0 of 100
| Odds Of DistressLess than 24
|
VERU INC is trading at 0.68 as of the 19th of December 2024. This is a 1.45% down since the beginning of the trading day. The stock's lowest day price was 0.68. VERU INC has about a 24 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 30th of December 2022 and ending today, the 19th of December 2024. Click here to learn more.
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. VERU INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. The company has 80.62 M outstanding shares. More on VERU INC DL 01
Moving together with VERU Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
VERU Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. VERU INC's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding VERU INC or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Charles Todd |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
VERU INC DL 01 (FMW) is traded on Frankfurt Exchange in Germany and employs 233 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 425.09 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate VERU INC's market, we take the total number of its shares issued and multiply it by VERU INC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. VERU INC DL classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 80.62 M outstanding shares.
VERU INC DL 01 has accumulated about 136.68 M in cash with 1.07 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check VERU INC Probability Of Bankruptcy
Ownership AllocationVERU INC DL shows a total of 80.62 Million outstanding shares. 30% of VERU INC DL outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Therefore, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check VERU Ownership Details
VERU INC DL Risk Profiles
Although VERU INC's alpha and beta are two of the key measurements used to evaluate VERU INC's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.95 | |||
| Standard Deviation | 4.0 | |||
| Variance | 15.99 | |||
| Risk Adjusted Performance | 0.0021 |
VERU Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in VERU INC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
VERU INC Corporate Management
Elected by the shareholders, the VERU INC's board of directors comprises two types of representatives: VERU INC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of VERU. The board's role is to monitor VERU INC's management team and ensure that shareholders' interests are well served. VERU INC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, VERU INC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jesus Socorro | Independent Director | Profile | |
| K Barnette | Chief Scientific Officer | Profile | |
| Grace Hyun | Independent Director | Profile | |
| Michael Rankowitz | Independent Director | Profile |
Other Information on Investing in VERU Stock
VERU INC financial ratios help investors to determine whether VERU Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in VERU with respect to the benefits of owning VERU INC security.